surmount trials tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Tirzepatide Delivers in SURMOUNT-2 -

Achieve sustainable results with personalized medical weight loss programs.

PlexusDx offers transparent pricing and licensed compounded semaglutide starting at $149 per month, with no insurance required

Achieve your health goals with specialized plans and support designed just for you.

Learn possible causes and when to seek advice.

federal judge ruled on Thursday against compounding pharmacies seeking permission to continue producing copies of Novo Nordisk's widely popular diabetes and weight-loss drugs, Ozempic and Wegovy, while a legal battle over drug shortages continues

Mounjaro, Ozampic and Wegovy Prime Medicare Colombo No 19, St Albans Place, Colombo 04 +94114242030